4.87% -0.11

Ovid Therapeutics Inc (OVID)

Überblick Nachrichten Preisverlauf Optionskette Financials Forum Prognose

Finanzdaten der Ovid Therapeutics Inc-Aktie (OVID)

*Alle Zahlen in Millionen

Enddatum des Zeitraums	2026-06-30	2026-03-31	2025-12-31	2025-09-30	2025-07-01
Periodenlänge	3 Monate	3 Monate	3 Monate	3 Monate	3 Monate
Revenues	0.733	-	0.718	0.132	6.272
Operating Expenses	7.93% 16.43	17.85	13.01	12.65	11.35
Operating Income/Loss	12.04% -15.70	-17.85	-12.29	-12.52	-5.073
Income/Loss From Continuing Operations Before Tax	11.65% -15.01	-16.99	9.663	-12.16	-4.684
Income Tax Expense/Benefit	-	-	-	-	-
Net Income/Loss	11.65% -15.01	-16.99	9.663	-12.16	-4.684

OLMA

$6.58

4.22%

ZVRA

$9.94

3.21%

SLDB

$5.53

3.66%

AVTX

$11.27

6.16%

NVCT

$18.60

1.74%

WVE

$3.13

1.88%